Jeet Mahal

Direttore operativo presso JASPER THERAPEUTICS, INC.

Patrimonio netto: 529 691 $ in data 30/04/2024

52 anni

64 relazioni

Consumer Services

Health Technology

Finance

Posizioni attive di Jeet Mahal

Società	Posizione	Inizio	Fine
JASPER THERAPEUTICS, INC.	Direttore operativo	21/03/2022	-
	Contatto Relazioni con gli Investitori	01/12/2019	-
	Direttore Finanziario/CFO	01/12/2019	25/09/2023
	Segretario Aziendale	01/12/2019	-

Storia della carriera di Jeet Mahal

Precedenti posizioni note di Jeet Mahal

Società	Posizione	Inizio	Fine
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/12/2009	01/12/2019
JOHNSON & JOHNSON	Corporate Officer/Principal	-	-
COR Therapeutics, Inc. COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction	Corporate Officer/Principal	-	-
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Corporate Officer/Principal	-	-

Formazione di Jeet Mahal

University of California, Berkeley	Undergraduate Degree
Illinois Institute of Technology	Graduate Degree
North Carolina State University	Graduate Degree
The Fuqua School of Business	Masters Business Admin
Duke University	Masters Business Admin

Statistiche

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	4
Graduate Degree	2
Masters Business Admin	2

Settori

Consumer Services	6
Health Technology	5
Finance	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	2
JASPER THERAPEUTICS, INC.	Finance
JOHNSON & JOHNSON	Health Technology

Aziende private	3
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Health Technology
COR Therapeutics, Inc. COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction	Health Technology

Vedi le connessioni aziendali